abrilumab
Sign in to saveAlso known as AMG 181
Abrilumab (INN; development code AMG 181) is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease.
In the Vinony graph
Vinony's link graph records 166 inbound references to abrilumab, and connects out to monoclonal antibody, lumiliximab and human.
It sits within the topics Chemical pages without DrugBank identifier, Chemicals that do not have a ChemSpider ID assigned and Drugs developed by AstraZeneca.
Vinony links it to 5 Wikipedia language editions.
~1 min read
Encyclopedic overview
1 sectionsContents
- References
Abrilumab (INN; development code AMG 181) is a monoclonal antibody designed for the treatment of inflammatory bowel disease, ulcerative colitis, and Crohn's disease.
This drug was developed by MedImmune.
Excerpted from Wikipedia’s “abrilumab” article, available under the CC BY-SA 4.0 licence.